[drugs targeting type 2 inflammation/lipid mediators - anti-ige antibody and crth2 antagonists].

[DRUGS TARGETING TYPE 2 INFLAMMATION/LIPID MEDIATORS - ANTI-IGE ANTIBODY AND CRTH2 ANTAGONISTS]. Arerugi. 2019;68(1):8-14 Authors: Asano K PMID: 30787248 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30787248?dopt=Abstract

Source: Arerugi - February 24, 2019 Category: Allergy & Immunology Authors: Asano K Tags: Arerugi Source Type: research

More News: